All In MedTech

Device Trial Radar · NCT05069558

Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Prospective Randomized Multi-center Controlled Clinical Investigation Comparing Patent Foramen Ovale (PFO) Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

450

Planned (sponsor's estimate)

Start

May 9, 2022

Primary completion

Nov 30, 2025

Study completion Nov 2029

Sponsor

Lead sponsor
Occlutech International ABNot on our public-company list
Sponsor type
Industry
First posted
Oct 6, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to investigate whether percutaneous PFO closure with the Occlutech Flex II PFO Occluder is non-inferior to the AMPLATZER™ PFO Occluder and Gore® Cardioform Septal Occluder in closure of the PFO, prevention of recurrent embolic stroke, and device/procedure related Serious Adverse Events (SAE).

Conditions

  • Stroke
  • Patent Foramen Ovale
  • PFO

Interventions

  • Investigational PFO Closure DeviceDevice

    Occlutech Flex II PFO Closure Device

  • Standard of Care PFO Closure DeviceDevice

    Amplatzer PFO Occluder and Gore Cardioform PFO Occluder

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effective Closure Rate of PFOTime frame: Twelve Months

Locations

48 sites in 8 countries. Site status is shown where the registry gives one.

  • Arizona Cardiovascular Research Center

    Phoenix, Arizona

47 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.